In November 2025, Abbott agreed to acquire Exact Sciences for approximately $21 billion. Madison, Wisconsin–based Exact ...

Pulse Biosciences (Nasdaq:PLSE) today announced clinical findings demonstrating the durability of its nPulse Vybrance system.

Stryker (NYSE: SYK) announced today that it launched its new SmartHospital platform aimed at transforming care delivery.

Olympus announced today that it appointed Denise Lane to the role of chief officer of inclusion (COI), effective April 1, ...

Stereotaxis (NYSE:STXS) today reported its fourth-quarter and full-year financial results ahead of expected growth in 2026.

Verily will integrate data from Samsung’s Galaxy Watch, enabling research sponsors to run real-world studies with re-contactable participants.

BTIG analysts continue to expect growth from Dexcom (Nasdaq:DXCM) after meeting with the company's senior investor relations (IR) officials.

View streamlines imaging analysis and visualization by using a suite of AI-enabled tools intended to aid clinical decision making.

SS Innovations (Nasdaq:SSII) announced today that it completed a private placement of common stock worth $18.6 million.

ReVision Implant announced today that it received FDA breakthrough device designation for its Occular visual cortical prosthesis.

Medline (Nasdaq:MDLN) today announced an underwritten public offering of 75 million shares of its Class A common stock.

BD (NYSE: BDX) announced today that it received CE mark approval for its Revello vascular covered stent system.